Together with the data from the in vitro pulldown with GST-FOXP1, these results provide strong evidence that that the IK6 deletion disrupts the Ikaros-FOXP1 interaction in B-ALL cells. The gene discussed is FOXP1; the disease is acute lymphoblastic leukemia.